Assistant Professor
Neurology
Dr. David N. Soleimani-Meigooni is a neurologist who cares for patients experiencing cognitive symptoms as a result of neurodegenerative diseases such as Alzheimer's disease.
In research, Soleimani-Meigooni focuses on advancing precision-medicine approaches to diagnosing Alzheimer's disease and other neurodegenerative diseases. He looks at using positron emission tomography (PET) to image amyloid-beta and tau (protein fragments that accumulate in the brains of people with the condition).
Soleimani-Meigooni earned his medical degree at UCSF. He completed a residency in neurology at Washington University School of Medicine in St. Louis, followed by a fellowship in cognitive and behavioral neurology at UCSF.
Publications
Calibration of multisite raters for prospective visual reads of amyloid PET scans.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.
Neurology. Clinical practice
Association of [ 18 F]Flortaucipir-PET and plasma p-tau217 with tau neuropathology in AD and other neurodegenerative disorders.
medRxiv : the preprint server for health sciences
Imaging Synaptic Density in Aging and Alzheimer Disease with [18F]SynVesT-1.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
Annals of neurology
18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.
Molecular neurodegeneration
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.
JAMA neurology
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
Annals of neurology
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.
Brain communications
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease.
Brain communications
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
Alzheimer's research & therapy
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimer's & dementia : the journal of the Alzheimer's Association
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
Alzheimer's & dementia : the journal of the Alzheimer's Association
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimer's & dementia : the journal of the Alzheimer's Association
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimer's & dementia : the journal of the Alzheimer's Association
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
Brain : a journal of neurology
Tau PET Visual Reads: Research and Clinical Applications and Future Directions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Brain : a journal of neurology
Pharmacokinetics of 38 Percent Silver Diamine Fluoride in Children.
Pediatric dentistry
Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
Neurobiology of aging
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
European journal of nuclear medicine and molecular imaging
Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum.
Cerebral cortex (New York, N.Y. : 1991)
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Brain : a journal of neurology
The impact of demographic, clinical, genetic, and imaging variables on tau PET status.
European journal of nuclear medicine and molecular imaging
Symptomatic amyloid-related imaging abnormalities in an APOE e4/e4 patient treated with aducanumab.
Alzheimer's & dementia (Amsterdam, Netherlands)
The Oxford Handbook of Adult Cognitive Disorders
Rapidly Progressive Dementia: Human Prion Diseases and an Approach for Evaluating Non-Prion Etiologies
The Structural Signature of Sporadic Creutzfeldt-Jakob Disease.
European journal of neurology
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.
Journal of neurovirology
Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.
Journal of applied clinical medical physics